Health News

New Delhi, July 01, 2023.Metropolis Healthcare on Metrobot, a unique chatbot designed exclusively for doctors. Metrobot, which is designed to revolutionize doctor-provider communication, eliminates the need for traditional call centres by providing doctors with a seamless WhatsApp-based chat platform, it claimed.According to the company’s press statement, doctors can use Metrobot to access essential medical information such as test availability, methodology, sample transport guidelines, turnaround time, sensitivity, specificity and cost, enhancing their decision-making process and providing patients with instant information and service.“The development of new ‘Metrobot’ involved extensive research and insights from more than 1000 doctors of various clinical specialties, ensurin...

Ahmedabad, June 2023.Intas Pharmaceuticals Ltd., one of India's leading pharmaceutical companies with operations across the globe has launched TOFATAS – a DCGI-approved, Tofacitinib Ointment 2% w/w for the treatment of mild to moderate Atopic Dermatitis (AD) in patients 18 years and above having flare-ups of the disease.Atopic Dermatitis (AD) is a chronic inflammatory, non-communicable, and relapsing skin disease that most often develops in all age groups. Atopic Dermatitis is a multifactorial disease arising from a complex interaction between genetic, environmental, and immunological factors. Despite unmet needs, approximately 15 years have passed since a topical therapy with a new mechanism of action for atopic dermatitis (AD) has been introduced in India. The quality of li...

Metropolis Healthcare Limited launches ‘Metrobot’ in India

Intas launches DCGI-approved Tofacitinib Topical